EUR 0.57
(-0.35%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 171.95 Million | 144.29 Million | 59.37 Million | -7.04 Million | 174.57 Million | 156.78 Million |
Net Income | 78.87 Million | 13.93 Million | -56.57 Million | -108.3 Million | 49.71 Million | 40.04 Million |
Depreciation & Amortization | 101.22 Million | 98.13 Million | 95.31 Million | 100.66 Million | 96.24 Million | 79.28 Million |
Deferred income taxes | -213.13 Million | - | - | - | - | 800 Thousand |
Stock-based compensation | 123 Thousand | - | - | - | - | - |
Change in working capital | -10.56 Million | 8.44 Million | 9000.00 | -15.93 Million | 2.91 Million | 14.06 Million |
Other non-cash items | 215.43 Million | 23.78 Million | 20.63 Million | 16.53 Million | 25.69 Million | 23.39 Million |
Investing Cash Flow | -27.51 Million | -200.33 Million | -19.37 Million | -99.9 Million | -60.69 Million | -35.66 Million |
Investments in PPE | -28.13 Million | -203.32 Million | -20.19 Million | -100.02 Million | -60.88 Million | -36.03 Million |
Acquisitions | 613 Thousand | 2.76 Million | 816 Thousand | 115 Thousand | 192 Thousand | 368 Thousand |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 1.94 Million | 215 Thousand | 3000.00 | 1000.00 | 1000.00 | 375 Thousand |
Financing Cash Flow | -217.44 Million | 43.42 Million | 59.71 Million | 95.91 Million | -157.18 Million | -127.85 Million |
Debt repayment | -195.92 Million | -110.05 Million | -14.66 Million | -14.66 Million | -79.75 Million | -189.96 Million |
Dividends payments | - | - | - | - | -33.44 Million | -20.09 Million |
Common Stock Repurchased | - | - | - | - | -46.88 Million | -1000.00 |
Common Stock Issuance | - | - | 34.63 Million | - | 12.03 Million | 89.33 Million |
Other Financing Activities | -21.51 Million | 153.47 Million | 39.75 Million | 110.57 Million | -9.12 Million | -7.13 Million |
Accounts receivables | 1.34 Million | -2.03 Million | -3.91 Million | 10.82 Million | 4.74 Million | 2.4 Million |
Accounts payables | -10.45 Million | 17.41 Million | 13.44 Million | -35.3 Million | -311 Thousand | 6.72 Million |
Inventory | -1.44 Million | -5.33 Million | -6.51 Million | 8.54 Million | -1.51 Million | 4.93 Million |
Other working capital | 1.71 Million | -1.6 Million | -3 Million | -36.86 Million | -311 Thousand | 9.13 Million |
Cash at beginning of period | 114.93 Million | 127.55 Million | 27.83 Million | 38.87 Million | 82.17 Million | 88.91 Million |
Cash at end of period | 41.92 Million | 114.93 Million | 127.55 Million | 27.83 Million | 38.87 Million | 82.17 Million |
Capital Expenditure | -28.13 Million | -203.32 Million | -20.19 Million | -100.02 Million | -60.88 Million | -36.03 Million |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -73.01 Million | -12.62 Million | 99.72 Million | -11.04 Million | -43.29 Million | -6.73 Million |
Free Cash Flow | 143.82 Million | -59.02 Million | 39.18 Million | -107.07 Million | 113.68 Million | 120.74 Million |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 36.81 Million | 6.1 Million | 2.57 Million | 2.16 Million | 78.87 Million | 48.68 Million |
Depreciation & Amortization | 24.38 Million | 24.31 Million | 24.64 Million | 25.48 Million | 101.22 Million | 25.24 Million |
Deferred income taxes | - | - | - | -74 Thousand | -213.13 Million | -25.29 Million |
Stock-based compensation | - | - | - | 74 Thousand | 123 Thousand | 49 Thousand |
Change in working capital | -13.64 Million | 8.95 Million | 155 Thousand | -2.78 Million | -10.56 Million | -22.29 Million |
Other non-cash items | 32.03 Million | 47.68 Million | 31.59 Million | 1.96 Million | 215.43 Million | 33.26 Million |
Investing Cash Flow | -5.4 Million | -4.38 Million | 18.1 Million | -5.51 Million | -27.51 Million | -5.78 Million |
Investments in PPE | -5.57 Million | -4.43 Million | -6.32 Million | -5.88 Million | -28.13 Million | -6.08 Million |
Acquisitions | 26 Thousand | 54 Thousand | 24.43 Million | 369 Thousand | 613 Thousand | 164 Thousand |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 170 Thousand | 315 Thousand | 24.09 Million | 897 Thousand | 1.94 Million | 133 Thousand |
Financing Cash Flow | -88.05 Million | -21.01 Million | -20.99 Million | -43.81 Million | -217.44 Million | -47.07 Million |
Debt repayment | -27.06 Million | -16.57 Million | -16.32 Million | -39.32 Million | -195.92 Million | -30.85 Million |
Dividends payments | -44.61 Million | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -16.37 Million | -8.53 Million | -7.33 Million | -4.49 Million | -21.51 Million | -16.21 Million |
Accounts receivables | 5.34 Million | 2.29 Million | -9.2 Million | 6.62 Million | 1.34 Million | 2.48 Million |
Accounts payables | -20.21 Million | 14.56 Million | 11.62 Million | -7.75 Million | -10.45 Million | -27.27 Million |
Inventory | 1.23 Million | -7.9 Million | -2.26 Million | -1.65 Million | -1.44 Million | 2.49 Million |
Other working capital | -20.21 Million | 14.56 Million | 11.62 Million | 1.71 Million | 1.71 Million | -27.27 Million |
Cash at beginning of period | 70.86 Million | 48.87 Million | 41.92 Million | 64.43 Million | 114.93 Million | 57.64 Million |
Cash at end of period | 32.6 Million | 70.86 Million | 48.87 Million | 41.92 Million | 41.92 Million | 64.43 Million |
Capital Expenditure | -5.57 Million | -4.43 Million | -6.32 Million | -5.88 Million | -28.13 Million | -6.08 Million |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -38.25 Million | 21.99 Million | 6.95 Million | -22.51 Million | -73.01 Million | 6.78 Million |
Free Cash Flow | 49.63 Million | 42.95 Million | 3.51 Million | 20.93 Million | 143.82 Million | 53.56 Million |
194480
ACNV
1053
KANCOTEA
7222
GRCM